• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

664.52 -3.43 (-0.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 581,778
Open 670.06
Bid (Size) 661.90 (80)
Ask (Size) 676.30 (40)
Prev. Close 667.95
Today's Range 658.50 - 676.66
52wk Range 541.00 - 821.11
Shares Outstanding 91,779,465
Dividend Yield 0.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right. ↗
July 02, 2026
Analysts have given Alnylam Pharmaceuticals an average price target of $436. 
Via The Motley Fool
News headline image
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% ↗
July 01, 2026
It might pull it off, provided several things fall right in place. 
Via The Motley Fool

Performance

YTD
-14.4%
-14.4%
1 Month
+10.4%
+10.4%
3 Month
-11.3%
-11.3%
6 Month
-16.6%
-16.6%
1 Year
+18.7%
+18.7%

More News

Read More
Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side ↗
June 29, 2026
Via Chartmill
REGN (NASDAQ:REGN) Presents a Classic Value Opportunity with Strong Fundamentals ↗
June 12, 2026
Via Chartmill
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
June 29, 2026
Via The Motley Fool
News headline image
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested ↗
June 27, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
June 25, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
2 Underrated Weight Loss Stocks to Buy and Hold ↗
June 23, 2026
Via The Motley Fool
News headline image
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
June 22, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
This Stock Is Up 58% This Year. Is It too Late to Buy? ↗
June 17, 2026
Via The Motley Fool
News headline image
3 Profitable Stocks We Think Twice About
June 17, 2026
Via StockStory
News headline image
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
June 09, 2026
From Pomerantz LLP
Via GlobeNewswire
Top S&P500 movers in Monday's session ↗
June 08, 2026
Via Chartmill
News headline image
Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
June 04, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why Regeneron (REGN) Stock Is Trading Up Today
June 03, 2026
Via StockStory
News headline image
2 S&P 500 Stocks with Solid Fundamentals and 1 We Find Risky
June 03, 2026
Via StockStory
Topics Stocks
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
June 02, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
3 Nasdaq 100 Stocks We Find Risky
June 01, 2026
Via StockStory
News headline image
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
May 28, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Commvault Systems, Inc. (NASDAQ: CVLT); MongoDB, Inc. (NASDAQ: MDB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN): Grabar Law Office is Investigating Claims on Your
May 27, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
May 26, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗
May 26, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Important Notice to Long-Term Shareholders of Molina Healthcare, Inc. (NYSE: MOH); MongoDB, Inc. (NASDAQ: MDB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Grabar Law Office is Investigating Claims on
May 26, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
Amylyx Stock: Why the Full Pipeline Story Matters ↗
May 24, 2026
Via MarketBeat

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 664.52
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 07/10/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 60.99B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 61B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap